Protea Biosciences Group, Inc.
CIK 0001335103
Revenue (TTM)
—
Q2 Aug 2017
Net Income (TTM)
−$18.69M
−63.4% YoY
Q2 Aug 2017
EPS Diluted (TTM)
—
Q2 Aug 2017
Gross Margin
—
Q2 Aug 2017
Operating Margin
—
Q2 Aug 2017
Net Margin
—
Q2 Aug 2017
Free Cash Flow (TTM)
—
Q2 Aug 2017
Cash
$82.65K
Q2 Aug 2017
Total Debt
$3.69M
Q2 Aug 2017
Shares Outstanding
397.07M sh
Q2 Aug 2017
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.